Back to Speakers

Eboni Cornish, MD

Presentation topic:

A Brain-First Framework Redefining Health and Longevity

Day 2 | 17 Oct | 1:35 PM - 2:35 PM

Presentation + Q&A

See Full Agenda

About the topic:

NeuroLongevity™ is a brain-first approach to health that shifts the focus from chasing symptoms to understanding and supporting the brain—the control center of the body. Designed for a broad audience, this framework explains why so many people struggle with brain fog, mood changes, low energy, and ongoing health issues despite doing “all the right things.”

This presentation combines advanced tools, such as single-photon emission computed tomography (SPECT), with a whole-body perspective to uncover what’s really driving these symptoms. One key theme is brain inflammation, which can quietly affect how you think, feel, and function long before more serious problems develop.

The NeuroLongevity™ roadmap offers a clear, practical path forward: calming the body’s stress response, supporting gut health, reducing toxin burden, identifying hidden contributors like infections, and using targeted strategies to help the brain heal and perform better.

You’ll also learn how natural hormonal changes across life can impact the brain, influencing mood, focus, and long-term health—making a brain-centered approach essential at every stage.

Learning objectives:

  • Understand how brain health impacts the entire body
  • Recognize common hidden drivers of fatigue, brain fog, and mood changes
  • Learn simple, practical strategies to support brain function and overall health
  • See how a brain-first approach can improve long-term outcomes

When you take care of your brain, you take care of your life—NeuroLongevity™ offers a new way to think about health and longevity.

About the speaker:

Dr. Eboni Cornish, MD, is the Associate Medical Director at Amen Clinics in Virginia and a physician specializing in neuroinflammation, complex chronic illness, and precision brain health. She is the President-Elect of ILADS (International Lyme and Associated Diseases Society). She is recognized for integrating functional medicine, advanced biomarker testing, and clinical neuroscience into the care of medically complex patients.

Dr. Cornish is the developer of the NeuroLongevity™ framework. This clinically grounded model combines functional brain imaging, molecular biomarkers, and comprehensive clinical history to identify underlying contributors to cognitive decline, neurological dysfunction, and chronic systemic illness. Her approach emphasizes root-cause evaluation of inflammation, infections, environmental exposures, immune imbalance, and metabolic factors that impact long-term brain performance and resilience.

She plays a key leadership role in advanced clinical programming at Amen Clinics, including scan-focused neuroinflammatory evaluations and the Neuroinflammatory Outpatient Intensive (NIOI), a structured program designed for patients with complex, treatment-sensitive neuroimmune presentations. Her clinical focus includes Lyme disease and co-infections, PANS/PANDAS, mold-related illness, chronic inflammatory response syndrome (CIRS), gut-brain dysfunction, autoimmune neuroinflammation, and environmentally driven neurological conditions.

In addition to her clinical work, Dr. Cornish is an international lecturer and educator who presents on neuroinflammation, biomarker-guided care, and integrative approaches to brain health and longevity. She is actively involved in clinical education, interdisciplinary collaboration, and advancing precision, patient-centered models of care that bridge immunology, neurology, and functional medicine.

Through her leadership, research-driven perspective, and commitment to comprehensive evaluation, Dr. Cornish continues to advance the NeuroLongevity™ model as a forward-thinking framework for restoring neurological stability, optimizing cognitive function, and supporting long-term brain health in complex clinical populations.

XYMOGEN XPERIENCE

Fitter. Smarter. Stronger. Longer.

October 16 - 18, 2026

Buy Tickets